Global Renal Cortical Necrosis Treatment Production, Demand and Key Producers, 2022-2028
This report studies the global Renal Cortical Necrosis Treatment demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Renal Cortical Necrosis Treatment, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Renal Cortical Necrosis Treatment that contribute to its increasing demand across many markets.
The global Renal Cortical Necrosis Treatment market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Renal Cortical Necrosis Treatment total market, 2017-2028, (USD Million)
Global Renal Cortical Necrosis Treatment total market by region & country, CAGR, 2017-2028, (USD Million)
U.S. VS China: Renal Cortical Necrosis Treatment total market, key domestic companies and share, (USD Million)
Global Renal Cortical Necrosis Treatment revenue by player and market share 2017-2022, (USD Million)
Global Renal Cortical Necrosis Treatment total market by Type, CAGR, 2017-2028, (USD Million)
Global Renal Cortical Necrosis Treatment total market by Application, CAGR, 2017-2028, (USD Million)
This reports profiles major players in the global Renal Cortical Necrosis Treatment market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Allergan plc, Amgen Inc., AstraZeneca plc, Baxter, Keryx Biopharmaceuticals, Inc, Teva Pharmaceutical Limited Inc, Pfizer, Novartis AG and Eisai Pharmaceuticals India Pvt. Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Renal Cortical Necrosis Treatment market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Renal Cortical Necrosis Treatment Market, By Region:
1. How big is the global Renal Cortical Necrosis Treatment market?
2. What is the demand of the global Renal Cortical Necrosis Treatment market?
3. What is the year over year growth of the global Renal Cortical Necrosis Treatment market?
4. What is the total value of the global Renal Cortical Necrosis Treatment market?
5. Who are the major players in the global Renal Cortical Necrosis Treatment market?
6. What are the growth factors driving the market demand?
This report is a detailed and comprehensive analysis of the world market for Renal Cortical Necrosis Treatment, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Renal Cortical Necrosis Treatment that contribute to its increasing demand across many markets.
The global Renal Cortical Necrosis Treatment market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Renal Cortical Necrosis Treatment total market, 2017-2028, (USD Million)
Global Renal Cortical Necrosis Treatment total market by region & country, CAGR, 2017-2028, (USD Million)
U.S. VS China: Renal Cortical Necrosis Treatment total market, key domestic companies and share, (USD Million)
Global Renal Cortical Necrosis Treatment revenue by player and market share 2017-2022, (USD Million)
Global Renal Cortical Necrosis Treatment total market by Type, CAGR, 2017-2028, (USD Million)
Global Renal Cortical Necrosis Treatment total market by Application, CAGR, 2017-2028, (USD Million)
This reports profiles major players in the global Renal Cortical Necrosis Treatment market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Allergan plc, Amgen Inc., AstraZeneca plc, Baxter, Keryx Biopharmaceuticals, Inc, Teva Pharmaceutical Limited Inc, Pfizer, Novartis AG and Eisai Pharmaceuticals India Pvt. Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Renal Cortical Necrosis Treatment market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Renal Cortical Necrosis Treatment Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Prednisolone
- Aspirin
- Sodium Bicarbonates
- N-acetyl Cysteine
- Statins
- Others
- Hospitals
- Cancer clinics
- Ambulatory Surgical Centers
- Others
- Allergan plc
- Amgen Inc.
- AstraZeneca plc
- Baxter
- Keryx Biopharmaceuticals, Inc
- Teva Pharmaceutical Limited Inc
- Pfizer
- Novartis AG
- Eisai Pharmaceuticals India Pvt. Ltd.
1. How big is the global Renal Cortical Necrosis Treatment market?
2. What is the demand of the global Renal Cortical Necrosis Treatment market?
3. What is the year over year growth of the global Renal Cortical Necrosis Treatment market?
4. What is the total value of the global Renal Cortical Necrosis Treatment market?
5. Who are the major players in the global Renal Cortical Necrosis Treatment market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Renal Cortical Necrosis Treatment Introduction
1.2 World Renal Cortical Necrosis Treatment Market Size & Forecast (2017 & 2021 & 2028)
1.3 World Renal Cortical Necrosis Treatment Total Market by Region
1.3.1 World Renal Cortical Necrosis Treatment Market Size by Region (2017-2028)
1.3.2 United States Renal Cortical Necrosis Treatment Market Size (2017-2028)
1.3.3 China Renal Cortical Necrosis Treatment Market Size (2017-2028)
1.3.4 Europe Renal Cortical Necrosis Treatment Market Size (2017-2028)
1.3.5 Japan Renal Cortical Necrosis Treatment Market Size (2017-2028)
1.3.6 South Korea Renal Cortical Necrosis Treatment Market Size (2017-2028)
1.3.7 ASEAN Renal Cortical Necrosis Treatment Market Size (2017-2028)
1.3.8 India Renal Cortical Necrosis Treatment Market Size (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Renal Cortical Necrosis Treatment Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Renal Cortical Necrosis Treatment Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 WORLD RENAL CORTICAL NECROSIS TREATMENT COMPANIES COMPETITIVE ANALYSIS
2.1 World Renal Cortical Necrosis Treatment Revenue by Player (2017-2022)
2.2 Industry Rank and Concentration Rate (CR)
2.2.1 Global Renal Cortical Necrosis Treatment Industry Rank of Major Players
2.2.2 Global Concentration Ratios (CR4) for Renal Cortical Necrosis Treatment in 2021
2.2.3 Global Concentration Ratios (CR8) for Renal Cortical Necrosis Treatment in 2021
2.3 Renal Cortical Necrosis Treatment Company Evaluation Quadrant
2.4 Renal Cortical Necrosis Treatment Market: Overall Company Footprint Analysis
2.4.1 Renal Cortical Necrosis Treatment Market: Region Footprint
2.4.2 Renal Cortical Necrosis Treatment Market: Company Product Type Footprint
2.4.3 Renal Cortical Necrosis Treatment Market: Company Product Application Footprint
2.5 Competitive Environment
2.5.1 Historical Structure of the Industry
2.5.2 Barriers of Market Entry
2.5.3 Factors of Competition
2.6 Mergers, Acquisitions Activity
3 UNITED STATES VS CHINA VS REST OF THE WORLD
3.1 United States VS China: Renal Cortical Necrosis Treatment Market Comparison
3.1.1 United States VS China: Renal Cortical Necrosis Treatment Market Size Comparison (2017 & 2021 & 2028)
3.1.2 United States VS China: Renal Cortical Necrosis Treatment Market Size Market Share Comparison (2017 & 2021 & 2028)
3.2 United States Renal Cortical Necrosis Treatment Major Players and Market Share, 2017-2022
3.2.1 Major Players of Renal Cortical Necrosis Treatment in United States, Headquarters (States, Country)
3.2.2 United States Renal Cortical Necrosis Treatment Revenue by Domestic Player, (2017-2022)
3.3 China Renal Cortical Necrosis Treatment Major Players and Market Share, 2017-2022
3.3.1 Major Players of Renal Cortical Necrosis Treatment in China, Headquarters (Province, Country)
3.3.2 China Renal Cortical Necrosis Treatment Revenue by Domestic Player, (2017-2022)
3.4 Rest of World Renal Cortical Necrosis Treatment Major Players and Market Share, 2017-2022
3.4.1 Major Players of Renal Cortical Necrosis Treatment in Rest of World, Headquarters (State, Country)
3.4.2 Rest of World Renal Cortical Necrosis Treatment Revenue by Domestic Player, (2017-2022)
4 MARKET ANALYSIS BY TYPE
4.1 World Renal Cortical Necrosis Treatment Market Size Overview by Type: 2017 VS 2021 VS 2028
4.2 Segment Introduction by Type
4.2.1 Prednisolone
4.2.2 Aspirin
4.2.3 Sodium Bicarbonates
4.2.4 N-acetyl Cysteine
4.2.5 Statins
4.2.6 Others
4.3 Market Segment by Type
4.3.1 World Renal Cortical Necrosis Treatment Market Size by Type (2017-2022)
4.3.2 World Renal Cortical Necrosis Treatment Market Size by Type (2023-2028)
4.3.3 World Renal Cortical Necrosis Treatment Market Size Market Share by Type (2017-2028)
5 MARKET ANALYSIS BY APPLICATION
5.1 World Renal Cortical Necrosis Treatment Market Size Overview by Application: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Application
5.2.1 Hospitals
5.2.2 Cancer clinics
5.2.3 Ambulatory Surgical Centers
5.2.4 Others
5.2.5 Others
5.3 Market Segment by Application
5.3.1 World Renal Cortical Necrosis Treatment Market Size by Application (2017-2022)
5.3.2 World Renal Cortical Necrosis Treatment Market Size by Application (2023-2028)
5.3.3 World Renal Cortical Necrosis Treatment Market Size by Application (2017-2028)
6 COMPANY PROFILES
6.1 Allergan plc
6.1.1 Allergan plc Details
6.1.2 Allergan plc Major Business
6.1.3 Allergan plc Renal Cortical Necrosis Treatment Product and Services
6.1.4 Allergan plc Renal Cortical Necrosis Treatment Revenue, Gross Margin and Market Share (2017-2022)
6.1.5 Allergan plc Recent Developments/Updates
6.1.6 Allergan plc Competitive Strengths & Weaknesses
6.2 Amgen Inc.
6.2.1 Amgen Inc. Details
6.2.2 Amgen Inc. Major Business
6.2.3 Amgen Inc. Renal Cortical Necrosis Treatment Product and Services
6.2.4 Amgen Inc. Renal Cortical Necrosis Treatment Revenue, Gross Margin and Market Share (2017-2022)
6.2.5 Amgen Inc. Recent Developments/Updates
6.2.6 Amgen Inc. Competitive Strengths & Weaknesses
6.3 AstraZeneca plc
6.3.1 AstraZeneca plc Details
6.3.2 AstraZeneca plc Major Business
6.3.3 AstraZeneca plc Renal Cortical Necrosis Treatment Product and Services
6.3.4 AstraZeneca plc Renal Cortical Necrosis Treatment Revenue, Gross Margin and Market Share (2017-2022)
6.3.5 AstraZeneca plc Recent Developments/Updates
6.3.6 AstraZeneca plc Competitive Strengths & Weaknesses
6.4 Baxter
6.4.1 Baxter Details
6.4.2 Baxter Major Business
6.4.3 Baxter Renal Cortical Necrosis Treatment Product and Services
6.4.4 Baxter Renal Cortical Necrosis Treatment Revenue, Gross Margin and Market Share (2017-2022)
6.4.5 Baxter Recent Developments/Updates
6.4.6 Baxter Competitive Strengths & Weaknesses
6.5 Keryx Biopharmaceuticals, Inc
6.5.1 Keryx Biopharmaceuticals, Inc Details
6.5.2 Keryx Biopharmaceuticals, Inc Major Business
6.5.3 Keryx Biopharmaceuticals, Inc Renal Cortical Necrosis Treatment Product and Services
6.5.4 Keryx Biopharmaceuticals, Inc Renal Cortical Necrosis Treatment Revenue, Gross Margin and Market Share (2017-2022)
6.5.5 Keryx Biopharmaceuticals, Inc Recent Developments/Updates
6.5.6 Keryx Biopharmaceuticals, Inc Competitive Strengths & Weaknesses
6.6 Teva Pharmaceutical Limited Inc
6.6.1 Teva Pharmaceutical Limited Inc Details
6.6.2 Teva Pharmaceutical Limited Inc Major Business
6.6.3 Teva Pharmaceutical Limited Inc Renal Cortical Necrosis Treatment Product and Services
6.6.4 Teva Pharmaceutical Limited Inc Renal Cortical Necrosis Treatment Revenue, Gross Margin and Market Share (2017-2022)
6.6.5 Teva Pharmaceutical Limited Inc Recent Developments/Updates
6.6.6 Teva Pharmaceutical Limited Inc Competitive Strengths & Weaknesses
6.7 Pfizer
6.7.1 Pfizer Details
6.7.2 Pfizer Major Business
6.7.3 Pfizer Renal Cortical Necrosis Treatment Product and Services
6.7.4 Pfizer Renal Cortical Necrosis Treatment Revenue, Gross Margin and Market Share (2017-2022)
6.7.5 Pfizer Recent Developments/Updates
6.7.6 Pfizer Competitive Strengths & Weaknesses
6.8 Novartis AG
6.8.1 Novartis AG Details
6.8.2 Novartis AG Major Business
6.8.3 Novartis AG Renal Cortical Necrosis Treatment Product and Services
6.8.4 Novartis AG Renal Cortical Necrosis Treatment Revenue, Gross Margin and Market Share (2017-2022)
6.8.5 Novartis AG Recent Developments/Updates
6.8.6 Novartis AG Competitive Strengths & Weaknesses
6.9 Eisai Pharmaceuticals India Pvt. Ltd.
6.9.1 Eisai Pharmaceuticals India Pvt. Ltd. Details
6.9.2 Eisai Pharmaceuticals India Pvt. Ltd. Major Business
6.9.3 Eisai Pharmaceuticals India Pvt. Ltd. Renal Cortical Necrosis Treatment Product and Services
6.9.4 Eisai Pharmaceuticals India Pvt. Ltd. Renal Cortical Necrosis Treatment Revenue, Gross Margin and Market Share (2017-2022)
6.9.5 Eisai Pharmaceuticals India Pvt. Ltd. Recent Developments/Updates
6.9.6 Eisai Pharmaceuticals India Pvt. Ltd. Competitive Strengths & Weaknesses
7 RAW MATERIAL AND INDUSTRY CHAIN
7.1 Raw Material of Renal Cortical Necrosis Treatment and Key Manufacturers
7.2 Renal Cortical Necrosis Treatment Manufacturing Costs
7.3 Renal Cortical Necrosis Treatment Production Process
7.4 Renal Cortical Necrosis Treatment Industrial Chain
8 DISTRIBUTION CHANNEL ANALYSIS
8.1 Distribution Channel Breakdown for Renal Cortical Necrosis Treatment Shipments (%): 2017-2028
8.1.1 Direct Channel
8.1.2 Indirect Channel
8.2 Renal Cortical Necrosis Treatment Typical Distributors
8.3 Renal Cortical Necrosis Treatment Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Renal Cortical Necrosis Treatment Introduction
1.2 World Renal Cortical Necrosis Treatment Market Size & Forecast (2017 & 2021 & 2028)
1.3 World Renal Cortical Necrosis Treatment Total Market by Region
1.3.1 World Renal Cortical Necrosis Treatment Market Size by Region (2017-2028)
1.3.2 United States Renal Cortical Necrosis Treatment Market Size (2017-2028)
1.3.3 China Renal Cortical Necrosis Treatment Market Size (2017-2028)
1.3.4 Europe Renal Cortical Necrosis Treatment Market Size (2017-2028)
1.3.5 Japan Renal Cortical Necrosis Treatment Market Size (2017-2028)
1.3.6 South Korea Renal Cortical Necrosis Treatment Market Size (2017-2028)
1.3.7 ASEAN Renal Cortical Necrosis Treatment Market Size (2017-2028)
1.3.8 India Renal Cortical Necrosis Treatment Market Size (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Renal Cortical Necrosis Treatment Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Renal Cortical Necrosis Treatment Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 WORLD RENAL CORTICAL NECROSIS TREATMENT COMPANIES COMPETITIVE ANALYSIS
2.1 World Renal Cortical Necrosis Treatment Revenue by Player (2017-2022)
2.2 Industry Rank and Concentration Rate (CR)
2.2.1 Global Renal Cortical Necrosis Treatment Industry Rank of Major Players
2.2.2 Global Concentration Ratios (CR4) for Renal Cortical Necrosis Treatment in 2021
2.2.3 Global Concentration Ratios (CR8) for Renal Cortical Necrosis Treatment in 2021
2.3 Renal Cortical Necrosis Treatment Company Evaluation Quadrant
2.4 Renal Cortical Necrosis Treatment Market: Overall Company Footprint Analysis
2.4.1 Renal Cortical Necrosis Treatment Market: Region Footprint
2.4.2 Renal Cortical Necrosis Treatment Market: Company Product Type Footprint
2.4.3 Renal Cortical Necrosis Treatment Market: Company Product Application Footprint
2.5 Competitive Environment
2.5.1 Historical Structure of the Industry
2.5.2 Barriers of Market Entry
2.5.3 Factors of Competition
2.6 Mergers, Acquisitions Activity
3 UNITED STATES VS CHINA VS REST OF THE WORLD
3.1 United States VS China: Renal Cortical Necrosis Treatment Market Comparison
3.1.1 United States VS China: Renal Cortical Necrosis Treatment Market Size Comparison (2017 & 2021 & 2028)
3.1.2 United States VS China: Renal Cortical Necrosis Treatment Market Size Market Share Comparison (2017 & 2021 & 2028)
3.2 United States Renal Cortical Necrosis Treatment Major Players and Market Share, 2017-2022
3.2.1 Major Players of Renal Cortical Necrosis Treatment in United States, Headquarters (States, Country)
3.2.2 United States Renal Cortical Necrosis Treatment Revenue by Domestic Player, (2017-2022)
3.3 China Renal Cortical Necrosis Treatment Major Players and Market Share, 2017-2022
3.3.1 Major Players of Renal Cortical Necrosis Treatment in China, Headquarters (Province, Country)
3.3.2 China Renal Cortical Necrosis Treatment Revenue by Domestic Player, (2017-2022)
3.4 Rest of World Renal Cortical Necrosis Treatment Major Players and Market Share, 2017-2022
3.4.1 Major Players of Renal Cortical Necrosis Treatment in Rest of World, Headquarters (State, Country)
3.4.2 Rest of World Renal Cortical Necrosis Treatment Revenue by Domestic Player, (2017-2022)
4 MARKET ANALYSIS BY TYPE
4.1 World Renal Cortical Necrosis Treatment Market Size Overview by Type: 2017 VS 2021 VS 2028
4.2 Segment Introduction by Type
4.2.1 Prednisolone
4.2.2 Aspirin
4.2.3 Sodium Bicarbonates
4.2.4 N-acetyl Cysteine
4.2.5 Statins
4.2.6 Others
4.3 Market Segment by Type
4.3.1 World Renal Cortical Necrosis Treatment Market Size by Type (2017-2022)
4.3.2 World Renal Cortical Necrosis Treatment Market Size by Type (2023-2028)
4.3.3 World Renal Cortical Necrosis Treatment Market Size Market Share by Type (2017-2028)
5 MARKET ANALYSIS BY APPLICATION
5.1 World Renal Cortical Necrosis Treatment Market Size Overview by Application: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Application
5.2.1 Hospitals
5.2.2 Cancer clinics
5.2.3 Ambulatory Surgical Centers
5.2.4 Others
5.2.5 Others
5.3 Market Segment by Application
5.3.1 World Renal Cortical Necrosis Treatment Market Size by Application (2017-2022)
5.3.2 World Renal Cortical Necrosis Treatment Market Size by Application (2023-2028)
5.3.3 World Renal Cortical Necrosis Treatment Market Size by Application (2017-2028)
6 COMPANY PROFILES
6.1 Allergan plc
6.1.1 Allergan plc Details
6.1.2 Allergan plc Major Business
6.1.3 Allergan plc Renal Cortical Necrosis Treatment Product and Services
6.1.4 Allergan plc Renal Cortical Necrosis Treatment Revenue, Gross Margin and Market Share (2017-2022)
6.1.5 Allergan plc Recent Developments/Updates
6.1.6 Allergan plc Competitive Strengths & Weaknesses
6.2 Amgen Inc.
6.2.1 Amgen Inc. Details
6.2.2 Amgen Inc. Major Business
6.2.3 Amgen Inc. Renal Cortical Necrosis Treatment Product and Services
6.2.4 Amgen Inc. Renal Cortical Necrosis Treatment Revenue, Gross Margin and Market Share (2017-2022)
6.2.5 Amgen Inc. Recent Developments/Updates
6.2.6 Amgen Inc. Competitive Strengths & Weaknesses
6.3 AstraZeneca plc
6.3.1 AstraZeneca plc Details
6.3.2 AstraZeneca plc Major Business
6.3.3 AstraZeneca plc Renal Cortical Necrosis Treatment Product and Services
6.3.4 AstraZeneca plc Renal Cortical Necrosis Treatment Revenue, Gross Margin and Market Share (2017-2022)
6.3.5 AstraZeneca plc Recent Developments/Updates
6.3.6 AstraZeneca plc Competitive Strengths & Weaknesses
6.4 Baxter
6.4.1 Baxter Details
6.4.2 Baxter Major Business
6.4.3 Baxter Renal Cortical Necrosis Treatment Product and Services
6.4.4 Baxter Renal Cortical Necrosis Treatment Revenue, Gross Margin and Market Share (2017-2022)
6.4.5 Baxter Recent Developments/Updates
6.4.6 Baxter Competitive Strengths & Weaknesses
6.5 Keryx Biopharmaceuticals, Inc
6.5.1 Keryx Biopharmaceuticals, Inc Details
6.5.2 Keryx Biopharmaceuticals, Inc Major Business
6.5.3 Keryx Biopharmaceuticals, Inc Renal Cortical Necrosis Treatment Product and Services
6.5.4 Keryx Biopharmaceuticals, Inc Renal Cortical Necrosis Treatment Revenue, Gross Margin and Market Share (2017-2022)
6.5.5 Keryx Biopharmaceuticals, Inc Recent Developments/Updates
6.5.6 Keryx Biopharmaceuticals, Inc Competitive Strengths & Weaknesses
6.6 Teva Pharmaceutical Limited Inc
6.6.1 Teva Pharmaceutical Limited Inc Details
6.6.2 Teva Pharmaceutical Limited Inc Major Business
6.6.3 Teva Pharmaceutical Limited Inc Renal Cortical Necrosis Treatment Product and Services
6.6.4 Teva Pharmaceutical Limited Inc Renal Cortical Necrosis Treatment Revenue, Gross Margin and Market Share (2017-2022)
6.6.5 Teva Pharmaceutical Limited Inc Recent Developments/Updates
6.6.6 Teva Pharmaceutical Limited Inc Competitive Strengths & Weaknesses
6.7 Pfizer
6.7.1 Pfizer Details
6.7.2 Pfizer Major Business
6.7.3 Pfizer Renal Cortical Necrosis Treatment Product and Services
6.7.4 Pfizer Renal Cortical Necrosis Treatment Revenue, Gross Margin and Market Share (2017-2022)
6.7.5 Pfizer Recent Developments/Updates
6.7.6 Pfizer Competitive Strengths & Weaknesses
6.8 Novartis AG
6.8.1 Novartis AG Details
6.8.2 Novartis AG Major Business
6.8.3 Novartis AG Renal Cortical Necrosis Treatment Product and Services
6.8.4 Novartis AG Renal Cortical Necrosis Treatment Revenue, Gross Margin and Market Share (2017-2022)
6.8.5 Novartis AG Recent Developments/Updates
6.8.6 Novartis AG Competitive Strengths & Weaknesses
6.9 Eisai Pharmaceuticals India Pvt. Ltd.
6.9.1 Eisai Pharmaceuticals India Pvt. Ltd. Details
6.9.2 Eisai Pharmaceuticals India Pvt. Ltd. Major Business
6.9.3 Eisai Pharmaceuticals India Pvt. Ltd. Renal Cortical Necrosis Treatment Product and Services
6.9.4 Eisai Pharmaceuticals India Pvt. Ltd. Renal Cortical Necrosis Treatment Revenue, Gross Margin and Market Share (2017-2022)
6.9.5 Eisai Pharmaceuticals India Pvt. Ltd. Recent Developments/Updates
6.9.6 Eisai Pharmaceuticals India Pvt. Ltd. Competitive Strengths & Weaknesses
7 RAW MATERIAL AND INDUSTRY CHAIN
7.1 Raw Material of Renal Cortical Necrosis Treatment and Key Manufacturers
7.2 Renal Cortical Necrosis Treatment Manufacturing Costs
7.3 Renal Cortical Necrosis Treatment Production Process
7.4 Renal Cortical Necrosis Treatment Industrial Chain
8 DISTRIBUTION CHANNEL ANALYSIS
8.1 Distribution Channel Breakdown for Renal Cortical Necrosis Treatment Shipments (%): 2017-2028
8.1.1 Direct Channel
8.1.2 Indirect Channel
8.2 Renal Cortical Necrosis Treatment Typical Distributors
8.3 Renal Cortical Necrosis Treatment Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Renal Cortical Necrosis Treatment Market Size by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Renal Cortical Necrosis Treatment Market Size by Region (2017-2022) & (USD Million)
Table 3. World Renal Cortical Necrosis Treatment Market Size by Region (2023-2028) & (USD Million)
Table 4. World Renal Cortical Necrosis Treatment Market Size Market Share by Region (2017-2022)
Table 5. World Renal Cortical Necrosis Treatment Market Size Market Share by Region (2023-2028)
Table 6. Major Market Trends
Table 7. World Renal Cortical Necrosis Treatment Revenue by Player (2017-2022) & (USD Million)
Table 8. Revenue Market Share of Key Renal Cortical Necrosis Treatment Players in 2021
Table 9. World Renal Cortical Necrosis Treatment Industry Rank of Major Player, Based on Revenue in 2021
Table 10. Global Renal Cortical Necrosis Treatment Company Evaluation Quadrant
Table 11. Head Office of Key Renal Cortical Necrosis Treatment Player
Table 12. Renal Cortical Necrosis Treatment Market: Company Product Type Footprint
Table 13. Renal Cortical Necrosis Treatment Market: Company Product Application Footprint
Table 14. Renal Cortical Necrosis Treatment Mergers & Acquisitions Activity
Table 15. United States VS China Renal Cortical Necrosis Treatment Market Size Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 16. Major Player of Renal Cortical Necrosis Treatment in United States, Headquarters (States, Country)
Table 17. United States Renal Cortical Necrosis Treatment Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 18. United States Renal Cortical Necrosis Treatment Revenue Market Share by Domestic Player, (2017-2022)
Table 19. Major Player of Renal Cortical Necrosis Treatment in China, Company Headquarters (Province, Country)
Table 20. China Renal Cortical Necrosis Treatment Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 21. China Renal Cortical Necrosis Treatment Revenue Market Share by Domestic Player, (2017-2022)
Table 22. Major Player of Renal Cortical Necrosis Treatment in Rest of World, Company Headquarters (State, Country)
Table 23. Rest of World Renal Cortical Necrosis Treatment Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 24. Rest of World Renal Cortical Necrosis Treatment Revenue Market Share by Domestic Player, (2017-2022)
Table 25. World Renal Cortical Necrosis Treatment Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 26. World Renal Cortical Necrosis Treatment Revenue by Type (2017-2022) & (USD Million)
Table 27. World Renal Cortical Necrosis Treatment Revenue by Type (2023-2028) & (USD Million)
Table 28. World Renal Cortical Necrosis Treatment Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 29. World Renal Cortical Necrosis Treatment Revenue by Application (2017-2022) & (USD Million)
Table 30. World Renal Cortical Necrosis Treatment Revenue by Application (2023-2028) & (USD Million)
Table 31. Allergan plc Basic Information, Manufacturing Base and Competitors
Table 32. Allergan plc Major Business
Table 33. Allergan plc Renal Cortical Necrosis Treatment Product and Services
Table 34. Allergan plc Renal Cortical Necrosis Treatment Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 35. Allergan plc Recent Developments/Updates
Table 36. Allergan plc Competitive Strengths & Weaknesses
Table 37. Amgen Inc. Basic Information, Manufacturing Base and Competitors
Table 38. Amgen Inc. Major Business
Table 39. Amgen Inc. Renal Cortical Necrosis Treatment Product and Services
Table 40. Amgen Inc. Renal Cortical Necrosis Treatment Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 41. Amgen Inc. Recent Developments/Updates
Table 42. Amgen Inc. Competitive Strengths & Weaknesses
Table 43. AstraZeneca plc Basic Information, Manufacturing Base and Competitors
Table 44. AstraZeneca plc Major Business
Table 45. AstraZeneca plc Renal Cortical Necrosis Treatment Product and Services
Table 46. AstraZeneca plc Renal Cortical Necrosis Treatment Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 47. AstraZeneca plc Recent Developments/Updates
Table 48. AstraZeneca plc Competitive Strengths & Weaknesses
Table 49. Baxter Basic Information, Manufacturing Base and Competitors
Table 50. Baxter Major Business
Table 51. Baxter Renal Cortical Necrosis Treatment Product and Services
Table 52. Baxter Renal Cortical Necrosis Treatment Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 53. Baxter Recent Developments/Updates
Table 54. Baxter Competitive Strengths & Weaknesses
Table 55. Keryx Biopharmaceuticals, Inc Basic Information, Manufacturing Base and Competitors
Table 56. Keryx Biopharmaceuticals, Inc Major Business
Table 57. Keryx Biopharmaceuticals, Inc Renal Cortical Necrosis Treatment Product and Services
Table 58. Keryx Biopharmaceuticals, Inc Renal Cortical Necrosis Treatment Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 59. Keryx Biopharmaceuticals, Inc Recent Developments/Updates
Table 60. Keryx Biopharmaceuticals, Inc Competitive Strengths & Weaknesses
Table 61. Teva Pharmaceutical Limited Inc Basic Information, Manufacturing Base and Competitors
Table 62. Teva Pharmaceutical Limited Inc Major Business
Table 63. Teva Pharmaceutical Limited Inc Renal Cortical Necrosis Treatment Product and Services
Table 64. Teva Pharmaceutical Limited Inc Renal Cortical Necrosis Treatment Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 65. Teva Pharmaceutical Limited Inc Recent Developments/Updates
Table 66. Teva Pharmaceutical Limited Inc Competitive Strengths & Weaknesses
Table 67. Pfizer Basic Information, Manufacturing Base and Competitors
Table 68. Pfizer Major Business
Table 69. Pfizer Renal Cortical Necrosis Treatment Product and Services
Table 70. Pfizer Renal Cortical Necrosis Treatment Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 71. Pfizer Recent Developments/Updates
Table 72. Pfizer Competitive Strengths & Weaknesses
Table 73. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 74. Novartis AG Major Business
Table 75. Novartis AG Renal Cortical Necrosis Treatment Product and Services
Table 76. Novartis AG Renal Cortical Necrosis Treatment Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 77. Novartis AG Recent Developments/Updates
Table 78. Eisai Pharmaceuticals India Pvt. Ltd. Basic Information, Manufacturing Base and Competitors
Table 79. Eisai Pharmaceuticals India Pvt. Ltd. Major Business
Table 80. Eisai Pharmaceuticals India Pvt. Ltd. Renal Cortical Necrosis Treatment Product and Services
Table 81. Eisai Pharmaceuticals India Pvt. Ltd. Renal Cortical Necrosis Treatment Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 82. Renal Cortical Necrosis Treatment Raw Material
Table 83. Key Manufacturers of Renal Cortical Necrosis Treatment Raw Materials
Table 84. Renal Cortical Necrosis Treatment Typical Distributors
Table 85. Renal Cortical Necrosis Treatment Typical Customers
Table 1. World Renal Cortical Necrosis Treatment Market Size by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Renal Cortical Necrosis Treatment Market Size by Region (2017-2022) & (USD Million)
Table 3. World Renal Cortical Necrosis Treatment Market Size by Region (2023-2028) & (USD Million)
Table 4. World Renal Cortical Necrosis Treatment Market Size Market Share by Region (2017-2022)
Table 5. World Renal Cortical Necrosis Treatment Market Size Market Share by Region (2023-2028)
Table 6. Major Market Trends
Table 7. World Renal Cortical Necrosis Treatment Revenue by Player (2017-2022) & (USD Million)
Table 8. Revenue Market Share of Key Renal Cortical Necrosis Treatment Players in 2021
Table 9. World Renal Cortical Necrosis Treatment Industry Rank of Major Player, Based on Revenue in 2021
Table 10. Global Renal Cortical Necrosis Treatment Company Evaluation Quadrant
Table 11. Head Office of Key Renal Cortical Necrosis Treatment Player
Table 12. Renal Cortical Necrosis Treatment Market: Company Product Type Footprint
Table 13. Renal Cortical Necrosis Treatment Market: Company Product Application Footprint
Table 14. Renal Cortical Necrosis Treatment Mergers & Acquisitions Activity
Table 15. United States VS China Renal Cortical Necrosis Treatment Market Size Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 16. Major Player of Renal Cortical Necrosis Treatment in United States, Headquarters (States, Country)
Table 17. United States Renal Cortical Necrosis Treatment Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 18. United States Renal Cortical Necrosis Treatment Revenue Market Share by Domestic Player, (2017-2022)
Table 19. Major Player of Renal Cortical Necrosis Treatment in China, Company Headquarters (Province, Country)
Table 20. China Renal Cortical Necrosis Treatment Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 21. China Renal Cortical Necrosis Treatment Revenue Market Share by Domestic Player, (2017-2022)
Table 22. Major Player of Renal Cortical Necrosis Treatment in Rest of World, Company Headquarters (State, Country)
Table 23. Rest of World Renal Cortical Necrosis Treatment Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 24. Rest of World Renal Cortical Necrosis Treatment Revenue Market Share by Domestic Player, (2017-2022)
Table 25. World Renal Cortical Necrosis Treatment Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 26. World Renal Cortical Necrosis Treatment Revenue by Type (2017-2022) & (USD Million)
Table 27. World Renal Cortical Necrosis Treatment Revenue by Type (2023-2028) & (USD Million)
Table 28. World Renal Cortical Necrosis Treatment Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 29. World Renal Cortical Necrosis Treatment Revenue by Application (2017-2022) & (USD Million)
Table 30. World Renal Cortical Necrosis Treatment Revenue by Application (2023-2028) & (USD Million)
Table 31. Allergan plc Basic Information, Manufacturing Base and Competitors
Table 32. Allergan plc Major Business
Table 33. Allergan plc Renal Cortical Necrosis Treatment Product and Services
Table 34. Allergan plc Renal Cortical Necrosis Treatment Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 35. Allergan plc Recent Developments/Updates
Table 36. Allergan plc Competitive Strengths & Weaknesses
Table 37. Amgen Inc. Basic Information, Manufacturing Base and Competitors
Table 38. Amgen Inc. Major Business
Table 39. Amgen Inc. Renal Cortical Necrosis Treatment Product and Services
Table 40. Amgen Inc. Renal Cortical Necrosis Treatment Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 41. Amgen Inc. Recent Developments/Updates
Table 42. Amgen Inc. Competitive Strengths & Weaknesses
Table 43. AstraZeneca plc Basic Information, Manufacturing Base and Competitors
Table 44. AstraZeneca plc Major Business
Table 45. AstraZeneca plc Renal Cortical Necrosis Treatment Product and Services
Table 46. AstraZeneca plc Renal Cortical Necrosis Treatment Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 47. AstraZeneca plc Recent Developments/Updates
Table 48. AstraZeneca plc Competitive Strengths & Weaknesses
Table 49. Baxter Basic Information, Manufacturing Base and Competitors
Table 50. Baxter Major Business
Table 51. Baxter Renal Cortical Necrosis Treatment Product and Services
Table 52. Baxter Renal Cortical Necrosis Treatment Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 53. Baxter Recent Developments/Updates
Table 54. Baxter Competitive Strengths & Weaknesses
Table 55. Keryx Biopharmaceuticals, Inc Basic Information, Manufacturing Base and Competitors
Table 56. Keryx Biopharmaceuticals, Inc Major Business
Table 57. Keryx Biopharmaceuticals, Inc Renal Cortical Necrosis Treatment Product and Services
Table 58. Keryx Biopharmaceuticals, Inc Renal Cortical Necrosis Treatment Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 59. Keryx Biopharmaceuticals, Inc Recent Developments/Updates
Table 60. Keryx Biopharmaceuticals, Inc Competitive Strengths & Weaknesses
Table 61. Teva Pharmaceutical Limited Inc Basic Information, Manufacturing Base and Competitors
Table 62. Teva Pharmaceutical Limited Inc Major Business
Table 63. Teva Pharmaceutical Limited Inc Renal Cortical Necrosis Treatment Product and Services
Table 64. Teva Pharmaceutical Limited Inc Renal Cortical Necrosis Treatment Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 65. Teva Pharmaceutical Limited Inc Recent Developments/Updates
Table 66. Teva Pharmaceutical Limited Inc Competitive Strengths & Weaknesses
Table 67. Pfizer Basic Information, Manufacturing Base and Competitors
Table 68. Pfizer Major Business
Table 69. Pfizer Renal Cortical Necrosis Treatment Product and Services
Table 70. Pfizer Renal Cortical Necrosis Treatment Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 71. Pfizer Recent Developments/Updates
Table 72. Pfizer Competitive Strengths & Weaknesses
Table 73. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 74. Novartis AG Major Business
Table 75. Novartis AG Renal Cortical Necrosis Treatment Product and Services
Table 76. Novartis AG Renal Cortical Necrosis Treatment Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 77. Novartis AG Recent Developments/Updates
Table 78. Eisai Pharmaceuticals India Pvt. Ltd. Basic Information, Manufacturing Base and Competitors
Table 79. Eisai Pharmaceuticals India Pvt. Ltd. Major Business
Table 80. Eisai Pharmaceuticals India Pvt. Ltd. Renal Cortical Necrosis Treatment Product and Services
Table 81. Eisai Pharmaceuticals India Pvt. Ltd. Renal Cortical Necrosis Treatment Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 82. Renal Cortical Necrosis Treatment Raw Material
Table 83. Key Manufacturers of Renal Cortical Necrosis Treatment Raw Materials
Table 84. Renal Cortical Necrosis Treatment Typical Distributors
Table 85. Renal Cortical Necrosis Treatment Typical Customers
LIST OF FIGURES
Figure 1. Renal Cortical Necrosis Treatment Picture
Figure 2. World Renal Cortical Necrosis Treatment Total Market Size: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Renal Cortical Necrosis Treatment Total Market Size (2017-2028) & (USD Million)
Figure 4. World Renal Cortical Necrosis Treatment Market Size Market Share by Region (2017-2028)
Figure 5. United States Renal Cortical Necrosis Treatment Market Size (2017-2028) & (USD Million)
Figure 6. China Renal Cortical Necrosis Treatment Market Size (2017-2028) & (USD Million)
Figure 7. Europe Renal Cortical Necrosis Treatment Market Size (2017-2028) & (USD Million)
Figure 8. Japan Renal Cortical Necrosis Treatment Market Size (2017-2028) & (USD Million)
Figure 9. South Korea Renal Cortical Necrosis Treatment Market Size (2017-2028) & (USD Million)
Figure 10. ASEAN Renal Cortical Necrosis Treatment Market Size (2017-2028) & (USD Million)
Figure 11. India Renal Cortical Necrosis Treatment Market Size (2017-2028) & (USD Million)
Figure 12. Renal Cortical Necrosis Treatment Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. Producer Shipments of Renal Cortical Necrosis Treatment by Player Revenue ($MM) and Market Share (%): 2021
Figure 15. Global Four-firm Concentration Ratios (CR4) for Renal Cortical Necrosis Treatment Markets in 2021
Figure 16. Global Four-firm Concentration Ratios (CR8) for Renal Cortical Necrosis Treatment Markets in 2021
Figure 17. United States VS China: Renal Cortical Necrosis Treatment Market Size Market Share Comparison (2017 & 2021 & 2028)
Figure 18. World Renal Cortical Necrosis Treatment Market Size by Type, (USD Million), 2017 & 2021 & 2028
Figure 19. World Renal Cortical Necrosis Treatment Market Size Market Share by Type in 2021
Figure 20. Prednisolone
Figure 21. Aspirin
Figure 22. Sodium Bicarbonates
Figure 23. N-acetyl Cysteine
Figure 24. Statins
Figure 25. Others
Figure 26. World Renal Cortical Necrosis Treatment Market Size Market Share by Type (2017-2028)
Figure 27. World Renal Cortical Necrosis Treatment Market Size by Application, (USD Million), 2017 & 2021 & 2028
Figure 28. World Renal Cortical Necrosis Treatment Market Size Market Share by Application in 2021
Figure 29. Hospitals
Figure 30. Cancer clinics
Figure 31. Ambulatory Surgical Centers
Figure 32. Others
Figure 33. World Renal Cortical Necrosis Treatment Market Size Market Share by Application (2017-2028)
Figure 34. Manufacturing Cost Structure Analysis of Renal Cortical Necrosis Treatment in 2021
Figure 35. Manufacturing Process Analysis of Renal Cortical Necrosis Treatment
Figure 36. Renal Cortical Necrosis Treatment Industrial Chain
Figure 37. Distribution Channel Breakdown for Renal Cortical Necrosis Treatment Shipments (%): 2017-2028
Figure 38. Direct Channel Pros & Cons
Figure 39. Indirect Channel Pros & Cons
Figure 40. Methodology
Figure 41. Research Process and Data Source
Figure 1. Renal Cortical Necrosis Treatment Picture
Figure 2. World Renal Cortical Necrosis Treatment Total Market Size: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Renal Cortical Necrosis Treatment Total Market Size (2017-2028) & (USD Million)
Figure 4. World Renal Cortical Necrosis Treatment Market Size Market Share by Region (2017-2028)
Figure 5. United States Renal Cortical Necrosis Treatment Market Size (2017-2028) & (USD Million)
Figure 6. China Renal Cortical Necrosis Treatment Market Size (2017-2028) & (USD Million)
Figure 7. Europe Renal Cortical Necrosis Treatment Market Size (2017-2028) & (USD Million)
Figure 8. Japan Renal Cortical Necrosis Treatment Market Size (2017-2028) & (USD Million)
Figure 9. South Korea Renal Cortical Necrosis Treatment Market Size (2017-2028) & (USD Million)
Figure 10. ASEAN Renal Cortical Necrosis Treatment Market Size (2017-2028) & (USD Million)
Figure 11. India Renal Cortical Necrosis Treatment Market Size (2017-2028) & (USD Million)
Figure 12. Renal Cortical Necrosis Treatment Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. Producer Shipments of Renal Cortical Necrosis Treatment by Player Revenue ($MM) and Market Share (%): 2021
Figure 15. Global Four-firm Concentration Ratios (CR4) for Renal Cortical Necrosis Treatment Markets in 2021
Figure 16. Global Four-firm Concentration Ratios (CR8) for Renal Cortical Necrosis Treatment Markets in 2021
Figure 17. United States VS China: Renal Cortical Necrosis Treatment Market Size Market Share Comparison (2017 & 2021 & 2028)
Figure 18. World Renal Cortical Necrosis Treatment Market Size by Type, (USD Million), 2017 & 2021 & 2028
Figure 19. World Renal Cortical Necrosis Treatment Market Size Market Share by Type in 2021
Figure 20. Prednisolone
Figure 21. Aspirin
Figure 22. Sodium Bicarbonates
Figure 23. N-acetyl Cysteine
Figure 24. Statins
Figure 25. Others
Figure 26. World Renal Cortical Necrosis Treatment Market Size Market Share by Type (2017-2028)
Figure 27. World Renal Cortical Necrosis Treatment Market Size by Application, (USD Million), 2017 & 2021 & 2028
Figure 28. World Renal Cortical Necrosis Treatment Market Size Market Share by Application in 2021
Figure 29. Hospitals
Figure 30. Cancer clinics
Figure 31. Ambulatory Surgical Centers
Figure 32. Others
Figure 33. World Renal Cortical Necrosis Treatment Market Size Market Share by Application (2017-2028)
Figure 34. Manufacturing Cost Structure Analysis of Renal Cortical Necrosis Treatment in 2021
Figure 35. Manufacturing Process Analysis of Renal Cortical Necrosis Treatment
Figure 36. Renal Cortical Necrosis Treatment Industrial Chain
Figure 37. Distribution Channel Breakdown for Renal Cortical Necrosis Treatment Shipments (%): 2017-2028
Figure 38. Direct Channel Pros & Cons
Figure 39. Indirect Channel Pros & Cons
Figure 40. Methodology
Figure 41. Research Process and Data Source
